(Q44648215)

5 December 2017

Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis (English)

1 reference

5 December 2017

0 references

0 references

1 reference

uterine carcinosarcoma

1 reference

Deepika Nemani

1

1 reference

5 December 2017

Nandita Mitra

series ordinal

2

1 reference

5 December 2017

Mengye Guo

series ordinal

3

1 reference

5 December 2017

Lilie Lin

series ordinal

4

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

5 December 2017

1 reference

5 December 2017

111

1 reference

5 December 2017

1

1 reference

5 December 2017

82-88

1 reference

Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

[Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Differences in Treatment and Outcome Between African-American and White Women With Endometrial Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Early-stage carcinosarcoma of the uterus: the significance of lymph node count

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Uterine sarcomas: a review of the Edinburgh experience from 1974 to 1992.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

The impact of adjuvant radiotherapy on carcinosarcoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

The central role of the propensity score in observational studies for causal effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Assessing the sensitivity of regression results to unmeasured confounders in observational studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Sensitivity of the hazard ratio to nonignorable treatment assignment in an observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

[Uterine sarcomas: clinical and therapeutic aspects (10 cases)]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Phase II trial of hydroxyurea, dacarbazine (DTIC), and etoposide (VP-16) in mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.05.016

10.1016/J.YGYNO.2008.05.016

7 January 2021

Identifiers

DOI

1 reference

OpenCitations bibliographic resource ID

5 December 2017

0 references

1 reference